Strongly agree on dual listing and very good point. They must consider a dual listing to start with. It's suicide if they don't.
Brainchip clearly is rushing to be only listed on the US exchange, to its detriment. Another start up biotechnology co I owned shares in listed in the US early without a dual listing and that didn't go too well. US marketplace can punish the share price if no deals are forthcoming, we need definitive news.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)